This study provides evidence for a novel role for NFKB2 in human B cell development in the bone marrow and in the periphery, leading to progressive peripheral B cell deficiency not always combined with autoimmune phenomena, broadening thus the clinical spectrum of NFKB2 mutated CVID disease and implying an essential role for NFKB2 in early human B cell development.
Keywords: Autoimmunity; B cells; Bone marrow; CVID; NFKB2.
Copyright © 2018 Elsevier Inc. All rights reserved.